Cargando…

Promising Druggable Target in Head and Neck Squamous Cell Carcinoma: Wnt Signaling

Canonical Wnt signaling pathway, also known as Wnt/β-catenin signaling pathway, is a crucial mechanism for cellular maintenance and development. It regulates cell cycle progression, apoptosis, proliferation, migration, and differentiation. Dysregulation of this pathway correlates with oncogenesis in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aminuddin, Amnani, Ng, Pei Yuen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982242/ https://www.ncbi.nlm.nih.gov/pubmed/27570510 http://dx.doi.org/10.3389/fphar.2016.00244

Ejemplares similares

Mitochondrial DNA sequences and transcriptomic profiles for elucidating the genetic underpinnings of cisplatin responsiveness in oral squamous cell carcinoma
por: Aminuddin, Amnani, et al.
Publicado: (2022)

Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma
por: Aminuddin, Amnani, et al.
Publicado: (2020)

Author Correction: Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma
por: Aminuddin, Amnani, et al.
Publicado: (2021)

Molecular Pathways and Druggable Targets in Head and Neck Squamous Cell Carcinoma
por: Kordbacheh, Farzaneh, et al.
Publicado: (2021)

Extracellular ATP Induced S-Phase Cell Cycle Arrest via P2Y Receptor-Activated ERK Signaling in Poorly Differentiated Oral Squamous Cell Carcinoma SAS Cells
por: Lau, Chia Chih, et al.
Publicado: (2021)

Wnt Signaling: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma
por: Javed, Zeeshan, et al.
Publicado: (2019)

Roles of the Wnt Signaling Pathway in Head and Neck Squamous Cell Carcinoma
por: Xie, Jing, et al.
Publicado: (2021)

Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma
por: Brkic, Faris F., et al.
Publicado: (2022)

Roles of Major RNA Adenosine Modifications in Head and Neck Squamous Cell Carcinoma
por: Huo, Xing-xing, et al.
Publicado: (2021)

The Significance of the Dysregulation of Canonical Wnt Signaling in Head and Neck Squamous Cell Carcinomas
por: Paluszczak, Jarosław
Publicado: (2020)

Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling
por: Bayle, Elliott D., et al.
Publicado: (2021)

An ErbB Lineage Co-Regulon Harbors Potentially Co-Druggable Targets for Multimodal Precision Therapy in Head and Neck Squamous Cell Carcinoma
por: Bredel, Markus, et al.
Publicado: (2022)

The role of novel programmed cell death in head and neck squamous cell carcinoma: from mechanisms to potential therapies
por: Xi, Yujie, et al.
Publicado: (2023)

Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck
por: Reuter, C W M, et al.
Publicado: (2007)

Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Pan, Yunbao, et al.
Publicado: (2019)

Amphipathic barbiturates as marine product mimics with cytolytic and immunogenic effects on head and neck squamous cell carcinoma cell lines
por: von Hofsten, Susannah, et al.
Publicado: (2023)

Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases
por: Grassi, Sara, et al.
Publicado: (2019)

Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets
por: Pelaia, Corrado, et al.
Publicado: (2022)

Revisiting the neuroinflammation hypothesis in Alzheimer’s disease: a focus on the druggability of current targets
por: Wong-Guerra, Maylin, et al.
Publicado: (2023)

The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches
por: Economopoulou, Panagiota, et al.
Publicado: (2017)

Identification of lncRNA Signature of Tumor-Infiltrating T Lymphocytes With Potential Implications for Prognosis and Chemotherapy of Head and Neck Squamous Cell Carcinoma
por: Wang, Liping, et al.
Publicado: (2022)

A novel necroptosis-related LncRNA signature for prediction of prognosis and therapeutic responses of head and neck squamous cell carcinoma
por: Meng, Zilu, et al.
Publicado: (2022)

Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment
por: Bhattacharjee, Bedanta, et al.
Publicado: (2023)

Locally advanced head and neck squamous cell carcinoma treatment efficacy and safety: a systematic review and network meta-analysis
por: Wang, Huanhuan, et al.
Publicado: (2023)

The Clinical Significance of Dickkopf Wnt Signaling Pathway Inhibitor Gene Family in Head and Neck Squamous Cell Carcinoma
por: Hu, Yuan, et al.
Publicado: (2020)

Druggable Targets of Squamous Cell Lung Cancer
por: Kim, Cheol Hyeon
Publicado: (2013)

HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma
por: Chen, Yan, et al.
Publicado: (2023)

Activation of Wnt/Beta-Catenin Signaling Pathway as a Promising Therapeutic Candidate for Cerebral Ischemia/Reperfusion Injury
por: Mo, Zhizhun, et al.
Publicado: (2022)

Deamidated Human Triosephosphate Isomerase is a Promising Druggable Target
por: Enríquez-Flores, Sergio, et al.
Publicado: (2020)

Wnt3a promotes radioresistance via autophagy in squamous cell carcinoma of the head and neck
por: Jing, Qiancheng, et al.
Publicado: (2019)

Genetic alterations in Wnt family of genes and their putative association with head and neck squamous cell carcinoma
por: Aditya, Jain, et al.
Publicado: (2021)

Probabilistic Pocket Druggability Prediction via One-Class Learning
por: Aguti, Riccardo, et al.
Publicado: (2022)

Exosomal microRNAs Targeting TP53 Gene as Promising Prognostic Markers for Head and Neck Squamous Cell Carcinoma
por: Jayaseelan, Vijayashree Priyadharsini, et al.
Publicado: (2022)

NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma
por: Shah, Pooja A., et al.
Publicado: (2020)

Niclosamide Induces Cell Cycle Arrest in G1 Phase in Head and Neck Squamous Cell Carcinoma Through Let-7d/CDC34 Axis
por: Han, Zewen, et al.
Publicado: (2019)

Mammalian target of rapamycin and head and neck squamous cell carcinoma
por: Liao, Yu-Min, et al.
Publicado: (2011)

An update on angiogenesis targeting in head and neck squamous cell carcinoma
por: Micaily, Ida, et al.
Publicado: (2020)

Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma
por: Liu, Shuo, et al.
Publicado: (2022)

Targeted therapy for head and neck squamous cell carcinoma microenvironment
por: Guo, Zhaomeng, et al.
Publicado: (2023)

Pharmacological Validation of ASIC1a as a Druggable Target for Neuroprotection in Cerebral Ischemia Using an Intravenously Available Small Molecule Inhibitor
por: Qi, Xin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oqlrnj61igoobck3o3umppipc8